Evidence map›Paper›PMID 38760407›Full record

ReviewNPJ digital medicine2024

An operational guide to translational clinical machine learning in academic medical centers.

Mukund Poddar, Jayson S Marwaha, William Yuan, Santiago Romero-Brufau, Gabriel A Brat

Abstract readReview
In one paragraph

Review in NPJ digital medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
  4. So You've Got a High AUC, Now What? An Overview of Important Considerations when Bringing Machine-Learning Models from Computer to Bedside.Medical decision making : an international journal of the Society for Medical Decision Making · 2025
    Review
  5. Article
  6. Review
  7. The Emergence of AI in Public Health Is Calling for Operational Ethics to Foster Responsible Uses.International journal of environmental research and public health · 2025
    Article
  8. Prospects and perils of ChatGPT in diabetes.World journal of diabetes · 2025
    Article
  9. Review
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Mukund Poddar *Department of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, USA.
Jayson S Marwaha *Department of Surgery, Beth Israel Deaconess Medical Center, Boston, MA, USA.ORCID http://orcid.org/0000-0002-3833-7448
William YuanDepartment of Surgery, Beth Israel Deaconess Medical Center, Boston, MA, USA.
Santiago Romero-BrufauDepartment of Biostatistics, Harvard T. H. Chan School of Public Health, Boston, MA, USA.ORCID http://orcid.org/0000-0002-9922-0083
Gabriel A BratDepartment of Surgery, Beth Israel Deaconess Medical Center, Boston, MA, USA. gbrat@bidmc.harvard.edu.ORCID http://orcid.org/0000-0003-3928-5931

Funding

RESEARCH TRAINING-MEDICAL INFORMATICS 90T15LM007092 · NLM · HARVARD UNIVERSITY (SCH OF PUBLIC HLTH) · PI Nils Gehlenborg · 1992 to 2026
$32.8M
Harvard Medical School CRICO/Risk Management FoundationHarvard University Blavatnik Biomedical Accelerator Pilot GrantHarvard University Harvard Data Science Public Service FellowHarvard University Harvard University Central GrantNLM NIH HHS T15 LM007092U.S. Department of Health & Human Services | NIH | U.S. National Library of Medicine (NLM) T15LM007092
6 · The paper itself

Abstract

Few published data science tools are ever translated from academia to real-world clinical settings for which they were intended. One dimension of this problem is the software engineering task of turning published academic projects into tools that are usable at the bedside. Given the complexity of the data ecosystem in large health systems, this task often represents a significant barrier to the real-world deployment of data science tools for prospective piloting and evaluation. Many information technology companies have created Machine Learning Operations (MLOps) teams to help with such tasks at scale, but the low penetration of home-grown data science tools in regular clinical practice precludes the formation of such teams in healthcare organizations. Based on experiences deploying data science tools at two large academic medical centers (Beth Israel Deaconess Medical Center, Boston, MA; Mayo Clinic, Rochester, MN), we propose a strategy to facilitate this transition from academic product to operational tool, defining the responsibilities of the principal investigator, data scientist, machine learning engineer, health system IT administrator, and clinician end-user throughout the process. We first enumerate the technical resources and stakeholders needed to prepare for model deployment. We then propose an approach to planning how the final product will work from data extraction and analysis to visualization of model outputs. Finally, we describe how the team should execute on this plan. We hope to guide health systems aiming to deploy minimum viable data science tools and realize their value in clinical practice.

Identifiers

PMID38760407
PMCPMC11101468

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.